YMR013W-A Antibody

What is YMR013W-A and why is it studied in yeast research?

YMR013W-A is a putative uncharacterized protein found in Saccharomyces cerevisiae strain 204508/S288c (Baker's yeast) . Despite being classified as "uncharacterized," this protein is of interest to researchers studying fundamental cellular processes in yeast as a model organism. The study of such proteins contributes to our understanding of yeast genomics, proteomics, and cellular function. Characterizing previously uncharacterized proteins often leads to discoveries of novel cellular mechanisms and pathways that may be conserved across species.

What are the specifications of commercially available YMR013W-A antibodies?

The commercially available YMR013W-A antibody is a rabbit polyclonal antibody specifically targeting the Saccharomyces cerevisiae (strain 204508/S288c) YMR013W-A protein . This antibody is purified through antigen-affinity methods and has an IgG isotype. It is validated for applications including ELISA (Enzyme-Linked Immunosorbent Assay) and Western Blot analyses, making it suitable for detecting and studying the YMR013W-A protein in various experimental settings .

What experimental applications are validated for YMR013W-A antibodies?

YMR013W-A antibodies are validated for several key experimental applications in yeast research:

• Western Blot (WB): For detecting the YMR013W-A protein in yeast lysates, allowing researchers to study protein expression levels, post-translational modifications, and molecular weight .

• ELISA (EIA): For quantitative detection of the YMR013W-A protein in solution, enabling precise measurement of protein concentration in various samples .

These validated applications make the antibody a versatile tool for both qualitative and quantitative analyses of the YMR013W-A protein in research settings.

How should I optimize Western Blot protocols for YMR013W-A antibody detection?

When optimizing Western Blot protocols for YMR013W-A antibody detection, consider the following methodological approach:

• Sample Preparation:

  • Use fresh yeast cultures in exponential growth phase

  • Extract proteins using mechanical disruption (glass beads) or enzymatic lysis

  • Include protease inhibitors to prevent protein degradation

  • Determine optimal protein loading (typically 20-50 μg total protein)

• Electrophoresis Conditions:

  • Select appropriate gel percentage (10-12% SDS-PAGE) for the expected molecular weight

  • Run samples alongside molecular weight markers

• Transfer and Blocking:

  • Optimize transfer conditions (voltage, time, buffer composition)

  • Block with 5% non-fat dry milk or BSA in TBST

• Antibody Incubation:

  • Test different dilutions of YMR013W-A antibody (starting with 1:1000)

  • Incubate overnight at 4°C for optimal sensitivity

  • Use appropriate secondary antibody (anti-rabbit IgG)

• Detection and Analysis:

  • Use enhanced chemiluminescence (ECL) for detection

  • Include positive controls (recombinant YMR013W-A protein) and negative controls

This systematic approach ensures reliable and reproducible detection of the YMR013W-A protein in yeast samples.

What are the recommended conditions for using YMR013W-A antibody in ELISA?

For optimal ELISA results using YMR013W-A antibody, follow these methodological guidelines:

• Plate Coating:

  • Coat ELISA plates with purified antigen or sample containing YMR013W-A

  • Use carbonate/bicarbonate buffer (pH 9.6) for coating

  • Incubate overnight at 4°C

• Blocking:

  • Block with 2-5% BSA or non-fat dry milk in PBS

  • Incubate for 1-2 hours at room temperature

• Antibody Dilutions:

  • Test a range of primary antibody dilutions (1:500-1:5000)

  • Optimize incubation time (1-2 hours at room temperature or overnight at 4°C)

  • Use HRP-conjugated anti-rabbit IgG as secondary antibody (typically 1:2000-1:5000)

• Detection:

  • Use TMB substrate for HRP detection

  • Read absorbance at 450 nm after stopping reaction with acid

• Controls:

  • Include positive control (purified YMR013W-A protein)

  • Include negative controls (unrelated yeast proteins)

  • Use antibody-only and substrate-only controls

These optimized conditions will help researchers achieve sensitive and specific detection of YMR013W-A in ELISA applications.

How can I validate the specificity of the YMR013W-A antibody in my experiments?

Validating antibody specificity is crucial for ensuring reliable experimental results. For YMR013W-A antibody, implement these validation approaches:

• Genetic Validation:

  • Compare signal between wild-type yeast and YMR013W-A knockout strains

  • Use yeast overexpressing YMR013W-A as a positive control

• Biochemical Validation:

  • Perform pre-absorption tests by incubating the antibody with purified recombinant YMR013W-A protein before use

  • If the signal disappears after pre-absorption, this confirms specificity

• Cross-Reactivity Testing:

  • Test the antibody against lysates from related yeast species

  • Examine potential cross-reactivity with homologous proteins

• Immunoprecipitation Validation:

  • Perform immunoprecipitation followed by mass spectrometry to confirm the identity of the pulled-down protein

• Alternative Antibody Comparison:

  • If available, compare results with different antibodies targeting YMR013W-A

  • Consistent results across different antibodies support specificity

These validation steps provide comprehensive evidence for antibody specificity, ensuring confident interpretation of experimental results.

How can YMR013W-A antibody be adapted for immunofluorescence microscopy in yeast cells?

While not explicitly validated for immunofluorescence, researchers can adapt the YMR013W-A antibody for this application through the following methodological approach:

• Cell Preparation:

  • Fix yeast cells with 4% paraformaldehyde (10-15 minutes)

  • Digest cell wall with zymolyase or lyticase to create spheroplasts

  • Permeabilize with 0.1% Triton X-100

• Antibody Optimization:

  • Test a range of antibody concentrations (starting with 1:100-1:500)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use fluorophore-conjugated anti-rabbit secondary antibodies (Alexa Fluor 488 or 594)

• Controls and Validation:

  • Include YMR013W-A knockout strains as negative controls

  • Co-stain with organelle markers to determine subcellular localization

  • Compare with tagged YMR013W-A protein (GFP-fusion) if available

• Image Acquisition Parameters:

  • Optimize exposure times to prevent photobleaching

  • Use appropriate filter sets for the chosen fluorophore

  • Collect Z-stack images to capture the full cell volume

This adaptation requires extensive validation but can provide valuable insights into the subcellular localization and dynamics of the YMR013W-A protein.

What approaches can be used to study protein-protein interactions involving YMR013W-A?

To investigate protein-protein interactions involving YMR013W-A, researchers can employ the following advanced methodological approaches:

• Co-Immunoprecipitation (Co-IP):

  • Use YMR013W-A antibody to immunoprecipitate the protein and its binding partners

  • Analyze the precipitated complex by mass spectrometry

  • Validate interactions by reverse Co-IP with antibodies against suspected partners

• Proximity-Dependent Biotin Identification (BioID):

  • Create fusion proteins of YMR013W-A with a biotin ligase (BirA*)

  • Identify biotinylated proximal proteins using streptavidin pulldown and mass spectrometry

• Yeast Two-Hybrid Screening:

  • Use YMR013W-A as bait in Y2H screens against yeast genomic libraries

  • Validate positive interactions with additional methods

• Fluorescence Resonance Energy Transfer (FRET):

  • Create fluorophore-tagged versions of YMR013W-A and potential partners

  • Measure energy transfer as evidence of protein proximity

• Split-Protein Complementation Assays:

  • Fuse YMR013W-A and candidate interactors to complementary fragments of reporter proteins (e.g., split-GFP)

  • Reconstitution of reporter activity indicates protein-protein interaction

These complementary approaches provide a comprehensive strategy for mapping the YMR013W-A interactome and understanding its functional roles within the cell.

How can I employ YMR013W-A antibody in chromatin immunoprecipitation (ChIP) studies?

Adapting YMR013W-A antibody for ChIP studies requires careful optimization and validation:

• Cross-linking Optimization:

  • Test different formaldehyde concentrations (0.75-1.5%)

  • Optimize cross-linking times (10-20 minutes at room temperature)

• Chromatin Preparation:

  • Lyse cells and isolate cross-linked chromatin

  • Sonicate to achieve fragments of 200-500 bp

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation Conditions:

  • Pre-clear chromatin with protein A/G beads

  • Optimize antibody concentration (typically 2-5 μg per reaction)

  • Include IgG control and input samples

• Washing and Elution:

  • Use stringent washing buffers to reduce background

  • Reverse cross-links and purify DNA

• Detection Methods:

  • Perform qPCR targeting suspected binding regions

  • For unbiased analysis, perform ChIP-seq

• Validation Approaches:

  • Compare results with ChIP using tagged YMR013W-A constructs

  • Test specificity using YMR013W-A knockout strains

Since YMR013W-A is described as a putative uncharacterized protein, its role in chromatin interactions would need substantial validation to confirm any DNA binding capability or chromatin association.

How should I address inconsistent Western blot results with YMR013W-A antibody?

When facing inconsistent Western blot results with YMR013W-A antibody, systematically investigate these potential causes and solutions:

• Sample Preparation Issues:

  • Ensure complete protein extraction using mechanical disruption

  • Verify protein integrity by Coomassie staining

  • Check for protease activity by adding additional protease inhibitors

  • Compare fresh vs. frozen samples to assess stability

• Antibody-Related Factors:

  • Test new antibody aliquots to rule out degradation

  • Optimize antibody concentration through titration

  • Extend primary antibody incubation time (overnight at 4°C)

  • Try different blocking agents (BSA vs. milk) to reduce background

• Technical Parameters:

  • Optimize transfer efficiency for the protein's molecular weight

  • Test different membrane types (PVDF vs. nitrocellulose)

  • Adjust exposure times during detection

• Expression Variability:

  • Consider growth conditions affecting YMR013W-A expression

  • Analyze protein expression across different growth phases

  • Examine regulation under various stress conditions

• Post-translational Modifications:

  • Investigate potential modifications affecting antibody recognition

  • Test phosphatase treatment if phosphorylation is suspected

This systematic troubleshooting approach helps identify and address the specific factors causing inconsistent results.

What strategies can resolve cross-reactivity issues with YMR013W-A antibody?

When encountering cross-reactivity with YMR013W-A antibody, implement these resolution strategies:

• Antibody Purification:

  • Perform affinity purification against the specific antigen

  • Use cross-adsorption against related yeast proteins

• Protocol Adjustments:

  • Increase washing stringency with higher salt or detergent concentrations

  • Adjust blocking conditions to reduce non-specific binding

  • Decrease antibody concentration to minimize low-affinity interactions

• Buffer Optimization:

  • Test different blocking buffers (milk, BSA, casein)

  • Add non-ionic detergents to reduce hydrophobic interactions

  • Include competing proteins to absorb cross-reactive antibodies

• Alternative Detection Methods:

  • Use more specific detection systems with lower background

  • Consider using secondary antibodies with reduced cross-reactivity

• Genetic Confirmation:

  • Compare signal patterns between wild-type and YMR013W-A knockout strains

  • Use this comparison to identify which bands represent true targets vs. cross-reactive proteins

These approaches systematically address cross-reactivity issues to improve the specificity of YMR013W-A antibody applications.

How can I quantitatively analyze YMR013W-A expression levels across different experimental conditions?

For quantitative analysis of YMR013W-A expression, implement these methodological approaches:

• Western Blot Quantification:

  • Use internal loading controls (e.g., GAPDH, actin)

  • Perform densitometric analysis with standard curve calibration

  • Apply statistical analysis to biological and technical replicates

• Quantitative ELISA:

  • Develop a sandwich ELISA using YMR013W-A antibody

  • Create standard curves with recombinant YMR013W-A protein

  • Calculate absolute protein quantities from unknown samples

• Mass Spectrometry-Based Quantification:

  • Use SILAC (Stable Isotope Labeling with Amino acids in Cell culture)

  • Implement selected reaction monitoring (SRM) for targeted quantification

  • Compare with antibody-based methods for validation

• Experimental Design Considerations:

  • Include appropriate time points to capture expression dynamics

  • Standardize cell densities across conditions

  • Normalize to total protein content

• Data Analysis and Presentation:

  • Apply appropriate statistical tests (ANOVA, t-tests)

  • Present data in standardized formats (fold-change, absolute quantities)

  • Calculate biological variability and technical reproducibility

How can YMR013W-A antibody be utilized in protein array or chip-based proteomic studies?

YMR013W-A antibody can be adapted for protein array and chip-based proteomic applications through these methodological approaches:

• Antibody Microarray Development:

  • Immobilize YMR013W-A antibody on activated glass slides

  • Optimize spotting buffer composition and density

  • Validate array performance with recombinant standards

• Reverse Phase Protein Arrays (RPPA):

  • Spot cell lysates from different conditions onto nitrocellulose

  • Probe with YMR013W-A antibody and fluorescent detection systems

  • Quantify signals to compare expression levels across samples

• Antibody-Paired Arrays:

  • Develop sandwich immunoassay format on chip platforms

  • Optimize capture and detection antibody concentrations

  • Establish limits of detection and dynamic range

• Multiplex Analysis:

  • Incorporate YMR013W-A detection into multiplex antibody panels

  • Ensure absence of cross-reactivity with other detection systems

  • Validate quantification in complex samples

• Data Analysis for Array-Based Studies:

  • Implement normalization strategies for cross-array comparison

  • Apply appropriate statistical methods for high-dimensional data

  • Integrate with other proteomic datasets

These approaches extend YMR013W-A antibody applications to high-throughput proteomic platforms, enabling systems-level analysis of this protein's expression and interactions.

What are the considerations for using YMR013W-A antibody in studying post-translational modifications?

When investigating post-translational modifications (PTMs) of YMR013W-A, consider these methodological approaches:

• PTM-Specific Detection Strategies:

  • Use general PTM stains (Pro-Q Diamond for phosphorylation, periodic acid-Schiff for glycosylation)

  • Follow up with YMR013W-A antibody detection to confirm identity

  • Consider generating modification-specific antibodies for common PTMs

• Enrichment Approaches:

  • Perform immunoprecipitation with YMR013W-A antibody

  • Analyze precipitated protein by mass spectrometry for PTM identification

  • Use PTM-specific enrichment (e.g., phosphopeptide enrichment) prior to analysis

• Modification-Altering Treatments:

  • Compare samples treated with phosphatases, deglycosylases, or deubiquitinases

  • Analyze mobility shifts in Western blots after treatment

  • Correlate treatments with antibody recognition patterns

• Context-Dependent Modification Analysis:

  • Study modifications under different stress conditions

  • Investigate cell-cycle-dependent modifications

  • Compare modifications across growth phases

• Functional Correlation:

  • Link specific modifications to protein localization, stability, or function

  • Use mutation of modification sites to confirm functional relevance

  • Correlate modification patterns with protein-protein interactions

These approaches provide a comprehensive strategy for characterizing post-translational modifications of the YMR013W-A protein, potentially revealing regulatory mechanisms affecting its function.